Efficacy and Outcome of Rapid Access Rheumatology Consultation: An Office-based Pilot Cohort Study
- 1 April 2016
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 43 (6), 1130-1135
- https://doi.org/10.3899/jrheum.151210
Abstract
Objective Waiting times for first appointments are a major obstacle to timely rheumatology care. To improve access, a cooperative of office-based rheumatologists established an immediate access network, offering brief initial assessments for patients with musculoskeletal problems. Methods Patients were assessed at presentation and followed up after 6 months. Data were analyzed regarding demographics, diagnostic accuracy, clinical variables such as pain levels, and care. Results There were 335 patients assessed in the 6 cooperating practices during dedicated office hours. There were 124 patients (38%) who had a symptom duration of < 3 months. For patients with rheumatoid arthritis (RA), this proportion was 43% (70% for self-referred patients with RA). In the 325 patients available for reassessment after 6 months, initially suspected diagnoses were confirmed in 88%. Confirmation rates were 93% for RA (59 patients) and 84% for spondyloarthritis (SpA; 46 patients). At the followup examination, the visual analog scale for pain in patients with RA had significantly decreased from a median (interquartile range) of 70 (57.75–80) to 27.5 (20–42). For patients with SpA, the decrease was from 65 (50–79) to 30 (20–40). Conclusion The Rapid Access Clinic resulted in a substantial improvement of access to rheumatology assessment. More than one-third of the patients presented < 3 months after symptom onset. Suspected diagnoses of inflammatory rheumatic diseases were confirmed in almost 90%. This initiative demonstrates the feasibility of a rapid access service and indicates high diagnostic accuracy in such a setting. In particular, with respect to early access, it compares favorably with similar hospital-based approaches.This publication has 20 references indexed in Scilit:
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 updateAnnals Of The Rheumatic Diseases, 2013
- Immediate access rheumatology clinic: efficiency and outcomesAnnals Of The Rheumatic Diseases, 2011
- Diagnosespektrum, Behandlungsindikation und Symptomdauer von Erstzuweisungen zum RheumatologenZeitschrift für Rheumatologie, 2010
- Delay in receiving rheumatology care leads to long‐term harmArthritis & Rheumatism, 2010
- Long‐term impact of delay in assessment of patients with early arthritisArthritis & Rheumatism, 2010
- Improved treatment strategies reduce the increased mortality risk in early RA patientsRheumatology, 2010
- Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of diseaseRheumatology, 2006
- Looking back: rheumatoid arthritis—aetiology, occurrence and mortalityRheumatology, 2005
- Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritisRheumatology, 2004
- Delay to institution of therapy and induction of remission using single‐drug or combination–disease‐modifying antirheumatic drug therapy in early rheumatoid arthritisArthritis & Rheumatism, 2002